Edition:
India

Caladrius Biosciences Reports Q3 Loss Per Share Of $0.36 From Continuing Operations


Friday, 9 Nov 2018 

Nov 8 (Reuters) - Caladrius Biosciences Inc ::CALADRIUS BIOSCIENCES REPORTS 2018 THIRD QUARTER FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.36 FROM CONTINUING OPERATIONS.CALADRIUS BIOSCIENCES - AS OF SEPT 30 CO HAD CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $46.1 MILLION VERSUS $60.1 MILLION AS OF DEC 31, 2017.CALADRIUS BIOSCIENCES - EXPECTS CASH BALANCE WILL ALLOW CO TO FUND CURRENT BUSINESS PLAN BEYOND 2019. 

Company Quote

2.27
-0.09 -3.81%
1:30am IST